Tuesday, 12 June 2012

Drug Discovery Portal


Drug discovery is a lengthy and expensive process with a low rate of new therapeutic discovery. Strathclyde Universities Drug Discovery Portal (DDP) can help expedite this process and provide access to novel compounds.
The DDP is based on a unique assembly of highly diverse compounds that are not otherwise commercially available. The compounds are initially used in silico for virtual screening, but they are linked to the originating chemists so that samples are available for physical screening and analogues can be rapidly designed and synthesised in order to understand structure-activity relationships. Hence, you can go quickly from a novel hit to an optimised candidate.
The chemical collection in the DDP has been assembled through links with groups of natural products and synthetic chemists from several academic institutions in four continents.
The DDP library contains over 14,000  compounds from participating researchers, the French Academic Compound Collection of over 40,000 compounds, and is being actively expanded by chemists worldwide.
Physical samples are rapidly available for assay validation and the DDP provides direct access to the expertise of the originating chemist for subsequent hit optimisation.

No comments:

Post a Comment

Note: only a member of this blog may post a comment.